Matt Hancock giving Downing Street coronavirus press briefing

The transcript discusses the UK's high enthusiasm for vaccines, the effectiveness of vaccine trials, and the challenges in measuring transmission reduction. It highlights the protection offered by the Pfizer vaccine and the need for vigilance. Promising results from Pfizer and AstraZeneca vaccines are noted, allowing for confident planning of the NHS rollout.

What is the UK's position in international studies regarding vaccine enthusiasm?

• Not ranked

• Quite near the top

• In the middle

• Near the bottom

Why is there uncertainty about the vaccine's impact on ending the pandemic?

• Unknown transmission reduction

• Lack of vaccine trials

• Vaccine side effects

• Insufficient vaccine doses

What percentage of protection does the Pfizer vaccine offer according to the speaker?

• 95%

• 85%

• 90%

• 100%

Which vaccines have shown promising results recently?

• Sinovac and Sputnik V

• Novavax and Covaxin

• Pfizer BIONTECH and Astra Zeneca Oxford

• Moderna and Johnson & Johnson

What is the speaker's outlook on the NHS's ability to plan the vaccine rollout?

• Confident

• Indifferent

• Uncertain

• Pessimistic